wase
CLOSE
WEBSITE OF THE STATE OF SOUTH DAKOTA DEPARTMENT OF HEALTH
Kim Malsam-Rysdon, Secretary of Health

South Dakota Department of Health Logo and covid.sd.gov button.

COVID-19 Vaccine Information for healthcare providers

NOTE: Please check this web page twice weekly for updated material.

Provider Enrollment Instructions

Vaccinator TrainingStorage & Handling TrainingVaccine Data Entry Training Vaccine Coordinator Training

Pfizer-BioNTech | Janssen | Moderna | Vaccine Finder | VAERS | V-Safe | Vaccine Resources | SD Vaccination Plan

Updates

On July 12, 2021, the FDA updated the Johnson & Johnson EUA fact sheet to include a warning about Guillain-Barre syndrome (GBS). View the updated J&J EUA Fact Sheet for Providers and the J&J EUA Fact Sheet for Caregivers and Recipients. Below is a statement from CDC on Guillain-Barre syndrome, and FAQs on GBS from the Public Health Communications Collaborative.

Note that GBS continues to remain rare, with only 100 cases reported to VAERS out of 12.8 million doses of J&J administered. These cases have been predominantly in male 50+, and the vast majority of GBS patients have recovered. GBS associated with the Johnson & Johnson COVID-19 vaccine is likely to be discussed on the next ACIP meeting on July 22, 2021.


 

Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Authorized in the U.S.
Summary of recent changes (last updated July 2, 2021):

  • New section on considerations for use of mRNA COVID-19 vaccines in people with a history of myocarditis or pericarditis added to considerations for vaccination of people with certain underlying medical conditions.

  • New information on the occurrence of myocarditis or pericarditis following vaccination with mRNA COVID-19 vaccines added to patient counseling.

Pfizer-BioNTech COVID-19 Vaccine

Pfizer-BioNTech Website

Pfizer-BioNTech for Adolescents 12 years and older

Pfizer-BioNTech Resources:

Contact Information: https://www.pfizer.com/contact

BACK TO TOP

Janssen COVID-19 Vaccine

Janssen Website

Janssen Resources:

Contact Information:

BACK TO TOP

Moderna COVID-19 Vaccine

Moderna Website

Moderna Resources:

Contact Information: 1-866-MODERNA (1-866-663-3762) - 24/7 Call Center

BACK TO TOP

VaccineFinder (VF)

Resources:

Contact Information:

BACK TO TOP

VAERS - Vaccine Adverse Event Reporting System

VAERS Website - Healthcare providers are required by law to report to VAERS

Contact VAERS at:

  • Phone: 800-822-7967 | Fax: 877-721-0366 | E-mail: info@vaers.org   
  • For non-urgent concerns, email covid19vaxsafety@cdc.gov. For emergencies relating to COVID-19 vaccine safety, call CDC Emergency Operations Center at (770) 488-7100.

BACK TO TOP

V-Safe

v-safe website - CDC is requesting that healthcare providers give patients a v-safe information sheet at the time of vaccination and encourage them to enroll and fill out the surveys when prompted to do so.

Contact Information: Call 800-232-4636 | TTY 888-232-6348 | Open 24 hours, 7 days a week

BACK TO TOP

General Vaccine Guidance & Resources

Vaccination Clinic Guidance

Long-Term Care Facility Guidance

Storage and Handling Guidance

Post-Vaccination Guidance

Fact Sheets & Communication Resources

BACK TO TOP

South Dakota Vaccination Plan

BACK TO TOP